000 | 01574 a2200409 4500 | ||
---|---|---|---|
005 | 20250516070801.0 | ||
264 | 0 | _c20120821 | |
008 | 201208s 0 0 eng d | ||
022 | _a1432-1041 | ||
024 | 7 |
_a10.1007/s00228-011-1171-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrennan, Meghan | |
245 | 0 | 0 |
_aMeta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics. _h[electronic resource] |
260 |
_bEuropean journal of clinical pharmacology _cMay 2012 |
||
300 |
_a645-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xblood |
650 | 0 | 4 | _aAxitinib |
650 | 0 | 4 | _aBiological Transport |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xblood |
650 | 0 | 4 |
_aIndazoles _xblood |
650 | 0 | 4 |
_aIsoenzymes _xgenetics |
650 | 0 | 4 |
_aOrganic Anion Transporters _xgenetics |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors |
700 | 1 | _aWilliams, J Andrew | |
700 | 1 | _aChen, Ying | |
700 | 1 | _aTortorici, Michael | |
700 | 1 | _aPithavala, Yazdi | |
700 | 1 | _aLiu, Yingxue Cathy | |
773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 68 _gno. 5 _gp. 645-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00228-011-1171-8 _zAvailable from publisher's website |
999 |
_c21392237 _d21392237 |